PRTC and VOR Related Headlines
Go Back- PureTech Health plc – Half-Year Report
- PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement
PRTC and VOR Related Press Releases
Go Back- PureTech Health plc – Half-Year Report
- PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement

